Inhibition of the key factors on the axis MyD88/TLR-CXCL2-CXCR2-NLRP3 may provide potential prevention and treatment strategies for liver fibrosis (Figure 8). This evidence concerns the gene CXCL2 and Hepatic fibrosis.